Katalog der Deutschen Nationalbibliothek

Go to:

Knowledge Web

Person
Person

Person

Wolfgang H. Jost (1959-)

Neurologe

Name

Wolfgang H. Jost

Time

1959- (Date of birth and death)

Place

Landau (Geburtsort)
Wiesbaden (Wirkungsort)
Wolfach (Wirkungsort)
Deutschland

Gender

männlich

Academic degree

Prof. Dr. med.

Profession

Neurologe (characteristic profession)
Arzt

Variant

Wolfgang Jost
W. H. Jost
W. Jost
Worufugangu Yosuto

Related

Deutsche Klinik für Diagnostik (Wiesbaden) (Leiter des Fachbereichs Neurologie, Klinische Neurophysiologie und Schmerztherapie) (1995-2013)
Parkinson-Klinik Ortenau (Chefarzt) (2013-)

Further information

Hauptarbeitsgebiete: Neurologie und Klinische Neurophysiologie

Source

Kürschner 2001
AM
LCAuth

Record type

Person

GND-Identifier

115190147

Record ID

115190147

Involved in

show all

How to treat cardiovascular autonomic failure in Parkinson’s disease

Motor and non-motor fluctuations in Parkinson’s disease: the knowns and unknowns of current therapeutic approaches

A call to action: revitalizing the German parkinson’s research ecosystem post-pandemic

Are we still treading water, or are we already moving ahead again?

Neuroimaging in advanced Parkinson’s disease: insights into pathophysiology, biomarkers, and personalized therapies

Levodopa treatment: impacts and mechanisms throughout Parkinson’s disease progression

Neuroimaging in multiple system atrophy: clinical implications and novel developments

Non motor Parkinson: subtypes, biomarkers, stepped care and a journal!

Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology

Parkinson-Krankheit – nicht-motorische Symptome für die Praxis : Teil 2: Gastrointestinale und urogenitale Störungen

Parkinson-Krankheit – nicht-motorische Symptome für die Praxis : Teil 1: Neuropsychiatrische und kardiovaskuläre Störungen

[18F]florzolotau PET for the differential diagnosis of parkinsonism in patients with suspected 4-repeat tauopathies

A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy

A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy

Amygdala neurodegeneration differentiates brain-first and body-first Parkinson's disease: an MRI study

Domain-specific brain regions are associated with cognitive impairment in progressive supranuclear palsy

Motor and non-motor fluctuations in Parkinson’s disease: the knowns and unknowns of current therapeutic approaches

Neuroimaging in advanced Parkinson’s disease: insights into pathophysiology, biomarkers, and personalized therapies

Tackling gender in progressive supranuclear palsy: Male patients present more apathy

Tackling gender in progressive supranuclear palsy: Male patients present more apathy

Advanced therapy in advanced Parkinson’s disease: money’s too tight to mention

Diagnostic and therapeutic challenges in PD-associated non-motor symptoms: the roles of neurologists and consultant physicians

Dopamine agonists in the treatment of Parkinson's disease: the show must go on

The akinetic crisis in Parkinson´s disease- the upper end of a spectrum of subacute akinetic states

Therapy with botulinum neurotoxin for Parkinson’s disease

Grasping the big picture: impact analysis of screening tools for timely referral for device-aided therapies

Intrajejunale L-Dopa-Applikation bei der Parkinson-Krankheit: Optimierung der PEG-Anlage

Sublingual apomorphine in the treatment of Parkinson’s disease

Every generation got its own disease

Advanced therapies in Parkinson’s disease: an individualized approach to their indication

Synergien statt Rivalitäten – die missverstandenen Rollen von kontinuierlicher intrajejunaler Levodopatherapie und Tiefer Hirnstimulation in der Behandlung des Morbus Parkinson – eine Expertenmeinung

Complemental Value of Microstructural and Macrostructural MRI in the Discrimination of Neurodegenerative Parkinson Syndromes

Advanced is advanced is advanced is advanced

A Short Progressive Supranuclear Palsy Quality of Life Scale

Advanced therapies in Parkinson’s disease: an individualized approach to their indication

Cerebellar, not nigrostriatal degeneration impairs dexterity in multiple system atrophy

Cerebral glucose metabolism is a valuable predictor of survival in patients with Lewy body diseases

Complemental value of microstructural and macrostructural MRI in the discrimination of neurodegenerative Parkinson syndromes

Intercultural translation and application of the German version of King’s Parkinson’s disease pain questionnaire in fluctuating Parkinson’s disease

Pain, disability, and quality of life in participants after concurrent onabotulinumtoxinA treatment of upper and lower limb spasticity: Observational results from the ASPIRE study

The connection of motor improvement after deep brain stimulation in Parkinson’s disease and microstructural integrity of the substantia nigra and subthalamic nucleus

Therapie der Parkinson-Krankheit

Therapie der Parkinson-Krankheit

Therapieansätze für das fortgeschrittene idiopathische Parkinson-Syndrom : Kontinuierliche dopaminerge Stimulationsverfahren im Überblick

The comorbidity and co-medication profile of patients with progressive supranuclear palsy

Towards improved access to device-aided therapies in advanced PD: the importance of cooperation of different disciplines

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson’s disease

Parkinson’s disease: a never ending story

Deep learning segmentation results in precise delineation of the putamen in multiple system atrophy

Apprends-moi l'art des petits pas: Levodopa, Carbidopa Intestinal Gel plus Entacapone

Inhaled levodopa for threatening impending OFF episodes in managing Parkinson’s disease

Clinical benefit of MAO-B and COMT inhibition in Parkinson’s disease: practical considerations

Optimised endoscopic access for intrajejunal levodopa application in idiopathic Parkinson's syndrome

If you can't be with the one you love, love the one you're with (C, S, N & Y)

Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children : update and practice recommendations

Deep learning segmentation results in precise delineation of the putamen in multiple system atrophy

The comorbidity and co-medication profile of patients with progressive supranuclear palsy

Therapie des fortgeschrittenen Parkinson-Syndroms

Therapie und Verlauf neurologischer Erkrankungen

Treatment of adult spasticity with Botox (onabotulinumtoxinA) : : development, insights, and impact
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal